PRCT vs STT · rev $224.5M vs P/E 17, $45.02B cap
Procept Biorobotics Corp (PRCT) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
State Street Corp (STT) is a asset management company listed on US.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
STT does not have a complete income-statement cache yet.
PRCT currently screens at market cap $1.52B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the PRCT and STT stock pages for the full models.
Not investment advice.